NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C. is investigating potential claims against Envision Healthcare Corporation (NYSE: EVHC). Our investigation concerns whether EVHC has violated the federal securities laws and/or engaged in other unlawful business practices.
On July 24, 2017, The New York Times reported that physicians associated with a subsidiary of Envision, EmCare Holdings, Inc., were disproportionately likely to engage in "surprise billing," which occurs when patients go to in-network hospitals, but are treated by out-of-network doctors and then billed at higher rates.
Following this news, shares of EVHC fell $3.73 over two trading days, or over 5.9%, to close at $58.88 on July 25, 2017.
If you purchased or otherwise acquired Envision Healthcare securities and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Envision Healthcare Corporation, please go to http://www.bespc.com/Envision. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.